161 related articles for article (PubMed ID: 34534157)
1. A Retrospective Study of Hearing Loss in Patients Diagnosed with Peroxisome Biogenesis Disorders in the Zellweger Spectrum.
Lee J; Yergeau C; Kawai K; Braverman N; Géléoc GSG
Ear Hear; 2022; 43(2):582-591. PubMed ID: 34534157
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype.
Enns GM; Ammous Z; Himes RW; Nogueira J; Palle S; Sullivan M; Ramirez C
Mol Genet Metab; 2021 Nov; 134(3):217-222. PubMed ID: 34625341
[TBL] [Abstract][Full Text] [Related]
3. A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers.
Wangler MF; Hubert L; Donti TR; Ventura MJ; Miller MJ; Braverman N; Gawron K; Bose M; Moser AB; Jones RO; Rizzo WB; Sutton VR; Sun Q; Kennedy AD; Elsea SH
Genet Med; 2018 Oct; 20(10):1274-1283. PubMed ID: 29419819
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.
Braverman NE; Raymond GV; Rizzo WB; Moser AB; Wilkinson ME; Stone EM; Steinberg SJ; Wangler MF; Rush ET; Hacia JG; Bose M
Mol Genet Metab; 2016 Mar; 117(3):313-21. PubMed ID: 26750748
[TBL] [Abstract][Full Text] [Related]
5. Two novel mutations of
Yu HL; Shen Y; Sun YM; Zhang Y
Ann Transl Med; 2019 Aug; 7(16):368. PubMed ID: 31555682
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder.
Demaret T; Roumain M; Ambroise J; Evraerts J; Ravau J; Bouzin C; Bearzatto B; Gala JL; Stepman H; Marie S; Vincent MF; Muccioli GG; Najimi M; Sokal EM
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165900. PubMed ID: 32693164
[TBL] [Abstract][Full Text] [Related]
7. Loss of Pex1 in Inner Ear Hair Cells Contributes to Cochlear Synaptopathy and Hearing Loss.
Mauriac SA; Peineau T; Zuberi A; Lutz C; Géléoc GSG
Cells; 2022 Dec; 11(24):. PubMed ID: 36552747
[TBL] [Abstract][Full Text] [Related]
8. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria as emergency landing for abandoned peroxins.
Vögtle FN; Meisinger C
EMBO Rep; 2021 Oct; 22(10):e53790. PubMed ID: 34414648
[TBL] [Abstract][Full Text] [Related]
10. Mild form of Zellweger Spectrum Disorders (ZSD) due to variants in
Barillari MR; Karali M; Di Iorio V; Contaldo M; Piccolo V; Esposito M; Costa G; Argenziano G; Serpico R; Carotenuto M; Cappuccio G; Banfi S; Melillo P; Simonelli F
Mol Genet Metab Rep; 2020 Sep; 24():100615. PubMed ID: 32596134
[TBL] [Abstract][Full Text] [Related]
11. Clinical, neuroradiological, and molecular characterization of patients with atypical Zellweger spectrum disorder caused by PEX16 mutations: a case series.
Cheung A; Argyriou C; Yergeau C; D'Souza Y; Riou É; Lévesque S; Raymond G; Daba M; Rtskhiladze I; Tkemaladze T; Adang L; La Piana R; Bernard G; Braverman N
Neurogenetics; 2022 Apr; 23(2):115-127. PubMed ID: 35106698
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.
Klouwer FCC; Ferdinandusse S; van Lenthe H; Kulik W; Wanders RJA; Poll-The BT; Waterham HR; Vaz FM
J Inherit Metab Dis; 2017 Nov; 40(6):875-881. PubMed ID: 28677031
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review.
Bose M; Yergeau C; D'Souza Y; Cuthbertson DD; Lopez MJ; Smolen AK; Braverman NE
Cells; 2022 Jun; 11(12):. PubMed ID: 35741019
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a severity scoring system for Zellweger spectrum disorders.
Klouwer FCC; Meester-Delver A; Vaz FM; Waterham HR; Hennekam RCM; Poll-The BT
Clin Genet; 2018 Mar; 93(3):613-621. PubMed ID: 28857144
[TBL] [Abstract][Full Text] [Related]
15. Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.
Lipiński P; Stawiński P; Rydzanicz M; Wypchło M; Płoski R; Stradomska TJ; Jurkiewicz E; Ferdinandusse S; Wanders RJA; Vaz FM; Tylki-Szymańska A
J Appl Genet; 2020 Feb; 61(1):87-91. PubMed ID: 31628608
[TBL] [Abstract][Full Text] [Related]
16. Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation.
Cheillan D
Adv Exp Med Biol; 2020; 1299():71-80. PubMed ID: 33417208
[TBL] [Abstract][Full Text] [Related]
17. The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder.
Hiebler S; Masuda T; Hacia JG; Moser AB; Faust PL; Liu A; Chowdhury N; Huang N; Lauer A; Bennett J; Watkins PA; Zack DJ; Braverman NE; Raymond GV; Steinberg SJ
Mol Genet Metab; 2014 Apr; 111(4):522-532. PubMed ID: 24503136
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives.
Braverman NE; D'Agostino MD; Maclean GE
Dev Disabil Res Rev; 2013; 17(3):187-96. PubMed ID: 23798008
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome biogenesis disorders.
Steinberg SJ; Dodt G; Raymond GV; Braverman NE; Moser AB; Moser HW
Biochim Biophys Acta; 2006 Dec; 1763(12):1733-48. PubMed ID: 17055079
[TBL] [Abstract][Full Text] [Related]
20. Novel PEX1 mutations in fibroblasts from children with Zellweger spectrum disorders exhibit temperature sensitive characteristics.
Liang JS; Hung KL; Lin LJ; Ong WP; Keng WT; Lu JF
Epilepsy Behav; 2023 Aug; 145():109266. PubMed ID: 37385119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
